Skip to content

Merck & Co. MRK Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Pfizer logo
PfizerPFE
6.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
United Therapeutics logo
United TherapeuticsUTHR
5%-3.8pp
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-7.1%-1.8pp

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$285.12B+31.2%
Enterprise value$328.82B+34.2%
P/E31.9×+19.4×
P/S4.3×+0.9×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Calculated from Merck & Co.’s reported figures.

Based on trailing twelve months.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s earnings yield?
Merck & Co. (MRK) reported earnings yield of 3% in Q1 2026.
How has Merck & Co.'s earnings yield changed year-over-year?
Merck & Co.'s earnings yield decreased by 60.9% year-over-year, from 7.7% to 3%.
What does earnings yield mean?
The company's annual profit as a percentage of its market price — the flip side of the P/E.
How do you interpret earnings yield?
Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
How does earnings yield compare across companies?
Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.